OS Benefit to Adding Fulvestrant to First-Line Anastrozole in HR-Positive Metastatic Breast Cancer - Cancer Therapy Advisor

OS Benefit to Adding Fulvestrant to First-Line Anastrozole in HR-Positive Metastatic Breast Cancer  Cancer Therapy Advisor

The survival benefit of anastrozole/fulvestrant combination therapy was more pronounced in the subgroup of patients who did not have prior exposure to ...



Comments

Popular posts from this blog

Epidemiology and prevention of venous thromboembolism